Abemacicib

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Abemacicib

Apr 29, 2024, 14:18 | Drugs

Matthew Goetz: Abemacicib in high risk ER+/HER2 negative breast cancer

Matthew Goetz, Professor of Oncology and Pharmacology at Mayo Clinic, shared on LinkedIn: “An important…

All: 1 Posts: 1 - 100

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Lyda Hill Philanthropies Was Honored with the American Cancer Society Philanthropist of the Year Award

Why President Biden Values Cancer Research So Much: The Story Behind Cancer Moonshot

The 2024 NIH Director’s Awards

Tedros Adhanom Ghebreyesus Received 2024 Rebranding Africa Forum Governance Leadership Award

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023